期刊文献+

高效液相色谱/质谱/质谱联用法测定人血浆中贝那普利及贝那普利拉浓度 被引量:2

Determination of benazepril and benazeprilate in human plasma by HPLC/MS/MS
暂未订购
导出
摘要 目的建立二级质谱与高效液相色谱联用的方法测定人血浆中贝那普利及其活性代谢产物贝那普利拉浓度的新方法。方法色谱柱为ZorbaxC18(5μm,4.6mm×150mm)。流动相为乙腈-10mmol/L乙酸胺(含0.08%NH3)(70∶30,v/v),流速1mL/min,柱后分流4∶1。样品经乙腈沉淀蛋白后直接进样。用选择离子分别对贝那普利、贝那普利拉和内标依拉普利进行检测。结果测定贝那普利及贝那普利拉的线性范围均为0.5~600μg/L,最低检测浓度为0.1μg/L。日内精密度<2.6%,日间精密度<3.5%。方法回收率范围为100.9%~110.2%。结论本方法精密、准确,适用于贝那普利及贝那普利拉的药物动力学及生物等效性研究。 [Objective] To constitute a HPLC-MS/MS method to determine serum benazepril and it active metabolites benazeprilate. [Method] Using Zorbax C18 Column and acetonitrile-10mM acetic ammonia (70:30, contain 0.08% ammonia) as the mobile phase. Blood sample were extract by using acetonitrile, and 20μL were applied to the HPLC system. Using selected iron to detect benazepril, benazeprilate and benapril respectively.[Result] The detective limited concentration is 0.1μg/L. The linear range of benazepril and benazeprilate are both in 0.5~600 μg/L. The within day RSD and between day RSD was 2.6% and 3.5% respectively in this linear range. Method recovery is within 100.9% to 110.2%. [Conclusion] The method is accuracy and sensitive enough to study on the Pharmacokinetics of benazepril and benazeprilate.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2005年第17期2630-2631,2635,共3页 China Journal of Modern Medicine
关键词 贝那普利 贝那普利拉 高效液相色谱/质谱法联用法 benazepril benazeprilate pharmacokinetics bioequivalence HPLC
  • 相关文献

参考文献3

  • 1MACDONALD N J, SIOUFI A, HOWIE CA, et al. The effects of age on the pharmacokinetics and pharmacody- namics of single oral doses of benazepril and enalapril[J]. Br J Pharmac, 1993,36: 205-209.
  • 2SUN IX, CIPRIANO A, JOHN VA. Pharmacokinetic interaction study between benazepril and amlodipine in healthy subjects [J].Eur J Clin Pharnmcol, 1994, 47: 285-289.
  • 3KAISER G, ACKERMANN R, DIETERLE W, et al. Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly[J]. Eur J Clin Pharmacol, 1990, 38:379-385.

同被引文献16

  • 1王雪丁,黄丽慧,曾桂雄,汤琤,钟国平,黄民.HPLC法同时测定健康人血浆中贝那普利及其代谢物贝那普利拉的浓度[J].中国临床药理学杂志,2005,21(4):292-295. 被引量:3
  • 2田蕾,黄一玲,宋蓉,华潞,况扶华,李一石.贝那普利人体药动学和生物等效性研究[J].中国现代应用药学,2007,24(1):36-39. 被引量:5
  • 3Gengo FM,Brady E. The pharmacokinetics of benazepril rela tive to other ACE inhibitors[J]. Clin Cardiol, 1991,14(8 Suppl 4) : IV44-50.
  • 4Jamerson K,Weber MA,Bakris GL,et al, Benazepril plus am- lodipine or hydrochlorothiazide for hypertension in high-risk patients[J]. N Engl J Med,2008,Dec 4,359(23):2417-2428.
  • 5Faulkner MA, Hilleman DE. Amlodipine/benazepril: fixed dose combination therapy for hypertension[J]. Expert-Opin Phar macother,2001,2( 1 ) :165- 178.
  • 6Pommier F, Boschet F, Gosset G. Quantitative determination of benazepril and benazeprilat in human plasma by gas chroma- tography-mass spectrometry using automated 96-well disk plate solid-phase extraction for sample preparation[J]. J Chro matogr B Analyt Technol Biomed Life Sci, 2003,783 ( 1 ) : 199-205.
  • 7Wang XD, Chan E, Chen X, et al. Simultaneous and rapid quan- titation of benazepril and benazeprilat in human plasma by high performance liquid chromatography with ultraviolet detection [J]. J Pharm Biomed Anal, 20117,44( 1 ): 224-230.
  • 8Pilli NR, Inamadugu JK, Mullangi R, et al. Simultaneous deter- mination of atorvastatin,amlodipine, ramipril and benazepril in human plasma by LC-MS/MS and its application to a human pharmacokinetic study[J]. Biomed Chromatogr, 2011,25 (4) : 439-449.
  • 9Xiao W, Chen B, Yao S, et al. Simultaneous determination of benazepril hydrochloride and benazeprilat in plasma by high performance liquid chromatography/electrospray-mass spec- trometry[J].J Chromatogr B Analyt Technol Biomed Life Sci, 2005,814(2) :303-308.
  • 10Cheng JW, Frishman WH, Aronow WS. Updates on Cyto chrome P450-Mediated Cardiovascular Drug Interactions[J]. Am J Therap, 2009,16 (2):155-163.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部